Back to search
FDAFDA · Food and drugs·Recall number D-0760-2022

quinapril HCl/hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0223-1

Published April 13, 2022 · Recall initiated: March 21, 2022

Summary

FDA records drug Class II recall D-0760-2022, published April 13, 2022 and initiated March 21, 2022. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 1104 bottles; Lot: Lot DP3414; Exp 02/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pfizer Inc.
Distributor
Nationwide
Lot
Lot DP3414; Exp 02/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was quinapril HCl/hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0223-1 recalled?

Yes. FDA published recall D-0760-2022 on April 13, 2022. Reported hazard: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release